4.3 Article

Pancreaticoduodenectomy with Harmonic Focus (R) Curved Shears for Cancer

Journal

DIGESTIVE SURGERY
Volume 31, Issue 4-5, Pages 249-254

Publisher

KARGER
DOI: 10.1159/000363071

Keywords

Pancreaticoduodenectomy; Pancreatic cancer; Ultrasonic dissection Harmonic Focus (R); Lymphadenectomy

Ask authors/readers for more resources

Ultrasonically activated shears enable the effective cutting and hemostasis of tissue, and have been shown to offer significant benefits in surgical procedures requiring fine dissection. Harmonic Focus (R), one of the latest ultrasonic devices, is a clip-like, light-weight, hand-held instrument with curved thin shears. Experience with Harmonic Focus in pancreatic surgery is limited. We have performed more than 1,000 pancreatic resections with this device. It may well represent a valuable tool for the extensive tissue and vascular dissection that is required in pancreaticoduodenectomy. In particular, Harmonic Focus performs very well in lymph node dissection, which is central in cancer surgery. In this report, we describe pancreaticoduodenectomy for pancreatic-head and periannpullary cancer with the Harmonic Focus device. (C) 2014 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Laura Maggino, Giuseppe Malleo, Stefano Crippa, Giulio Belfiori, Sara Nobile, Giulia Gasparini, Gabriella Lionetto, Claudio Luchini, Paola Mattiolo, Marco Schiavo-Lena, Claudio Doglioni, Aldo Scarpa, Claudio Bassi, Massimo Falconi, Roberto Salvia

Summary: This study investigated the incidence and pattern of recurrence in patients with initially resectable and borderline resectable pancreatic ductal adenocarcinoma who received post-neoadjuvant pancreatectomy. The results showed that preoperative tumor size <20 mm, normal posttreatment CA19.9 and Delta CA19.9 > 50% were associated with longer recurrence-free survival (RFS) in these patients.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better?

Laura Maggino, Giuseppe Malleo, Stefano Crippa, Massimo Falconi, Roberto Salvia

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Surgery

Early postoperative risk stratification in patients with pancreatic fistula after pancreaticoduodenectomy

Syed S. Raza, Anisa Nutu, Sarah Powell-Brett, Alessio Marchetti, Giampaolo Perri, Amanda Carvalheiro Boteon, James Hodson, Nikolaos Chatzizacharias, Bobby Dasari, John Isaac, Manual Abradelo, Ravi Marudanayagam, Darius F. Mirza, J. Keith Roberts, Giovanni Marchegiani, Roberto Salvia, Robert P. Sutcliffe

Summary: This study aimed to identify early postoperative variables that may predict the severity of postoperative pancreatic fistula. The study found that male sex, drain fluid amylase level on postoperative day 3, c-reactive protein level on postoperative day 3, and albumin level on postoperative day 3 were significant predictors of clinically relevant postoperative pancreatic fistula.

SURGERY (2023)

Article Pathology

Acinar Cystic Transformation of the Pancreas Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature

Claudio Luchini, Paola Mattiolo, Olca Basturk, Andrea Mafficini, Kerem Ozcan, Rita T. Lawlor, Seung-Mo Hong, Lodewijk A. Brosens, Giovanni Marchegiani, Antonio Pea, Erminia Manfrin, Giuseppe Sciacca, Federica Zampieri, Rita Polati, Riccardo De Robertis, Michele Milella, Mirko D'Onofrio, Giuseppe Malleo, Roberto Salvia, Volkan Adsay, Aldo Scarpa

Summary: Acinar cystic transformation (ACT) of the pancreas is a poorly understood and rare entity among pancreatic cystic lesions. This study aims to clarify its real nature by describing the clinicopathological features and molecular profile of a cohort of 25 patients with pancreatic ACT. The findings suggest that ACT is a benign entity potentially arising from diverse conditions/backgrounds, but the presence of driver mutations raises the possibility of long-term surveillance for these patients.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2023)

Article Surgery

Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features

Elisa Bannone, Giovanni Marchegiani, Giulia Angela Zamboni, Bogdan Mihai Maris, Lorenzo Costa, Giuseppa Procida, Pier Giuseppe Vacca, Mirko D'Onofrio, Giancarlo Mansueto, Enrique De-Madaria, Roberto Salvia, Claudio Bassi

Summary: This study systematically investigates the early radiologic, biochemical, and clinical features of postpancreatectomy acute pancreatitis. The results show that patients with postoperative serum hyperamylasemia and postpancreatectomy acute pancreatitis have lower apparent diffusion coefficient values at diffusion-weighted magnetic resonance imaging, but no macroscopic features consistent with acute pancreatitis. Subsequent imaging reveals that patients with radiologic features of acute pancreatitis have worse outcomes and all patients with radiologic features also have postoperative serum hyperamylasemia. The findings pave the way for the transfer of treatment strategies for acute pancreatitis into managing postpancreatectomy acute pancreatitis.

SURGERY (2023)

Review Surgery

Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting

Tamir N. Sholklapper, Jorge Ballon, Aref S. Sayegh, Anibal La Riva, Laura C. Perez, Sherry Huang, Michael Eppler, Gregg Nelson, Giovanni Marchegiani, Robert Hinchliffe, Luca Gordini, Marc Furrer, Michael J. Brenner, Salome Dell-Kuster, Chandra Shekhar Biyani, Nader Francis, Haytham M. A. Kaafarani, Matthias Siepe, Des Winter, Julie A. Sosa, Francesco Bandello, Robert Siemens, Jochen Walz, Alberto Briganti, Christian Gratzke, Andre L. Abreu, Mihir M. Desai, Rene Sotelo, Riaz Agha, Keith D. Lillemoe, Steven Wexner, Gary S. Collins, Inderbir Gill, Giovanni E. Cacciamani

Summary: This study assesses the prevalence and typology of perioperative adverse event reporting guidelines among surgery and anesthesiology journals. Results show that 46.5% of the queried journals recommend surgical adverse event reporting. Journals in the surgery, urology, and anesthesia categories are most likely to recommend reporting; those in the top SJR quartiles and based in Western Europe, North America, and the Middle East are also more likely to recommend.

INTERNATIONAL JOURNAL OF SURGERY (2023)

Editorial Material Gastroenterology & Hepatology

Simulation Model of Pancreatic Cancer Precursors Progression: Timely Surgery Does Not Equal Opportune (Anymore)

Giampaolo Perri, Giovanni Marchegiani

GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy

Tommaso Pollini, Giovanni Marchegiani, Antonio Facciorusso, Alberto Balduzzi, Marco Biancotto, Claudio Bassi, Ajay Maker, Roberto Salvia

Summary: Mucinous Cystic Neoplasms (MCN) of the pancreas have a 16.1% rate of malignancy, with studies published before 2012 having a higher rate compared to recent studies. Larger size and presence of mural nodules are associated with an increased risk of malignant MCN.
Article Surgery

Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022

Ugo Boggi, Greta F. Donisi, Niccolo F. Napoli, Stefano Partelli, Alessandro Esposito, Giovanni Ferrari, Giovanni Butturini, Luca Morelli, Mohammad Abu Hilal, Massimo Viola, Fabrizio Di Benedetto, Roberto Troisi, Marco Vivarelli, Elio Jovine, Alessandro Ferrero, Umberto Bracale, Sergio Alfieri, Riccardo Casadei, Giorgio Ercolani, Luca Moraldi, Carlo Molino, Raffaele Dalla Valle, Giuseppe Ettorre, Riccardo L. Memeo, Giacomo Zanus, Andrea Belli, Salvatore Gruttadauria, Alberto Brolese, Andrea Coratti, Gianluca Garulli, Renato Romagnoli, Marco Massani, Felice Borghi, Giulio Belli, Roberto Coppola, Massimo Falconi, Roberto Salvia, Alessandro Zerbi, IGOMPIS registry

Summary: This retrospective analysis of the IGOMIPS registry in Italy examined 1191 minimally invasive pancreatic resections with various procedures. The study found that robotic assistance improved surgical outcomes and reduced complications. High-volume centers and standardized pathology were also associated with better results. Further research is needed to fully understand the implementation of MIPR in Italy.

UPDATES IN SURGERY (2023)

Article Health Care Sciences & Services

Preoperative Anxiety in Patients with Pancreatic Cancer: What Contributes to Anxiety Levels in Patients Waiting for Surgical Intervention

Veronica Marinelli, Maria Angela Mazzi, Michela Rimondini, Olivia Purnima Danzi, Deborah Bonamini, Claudio Bassi, Roberto Salvia, Lidia Del Piccolo

Summary: Pancreatic cancer is a highly lethal malignancy and surgical resection is the only treatment option. However, preoperative anxiety significantly affects patients' quality of life and surgical outcomes. This observational study aimed to identify the socio-demographic, clinical, and psychological characteristics that contribute to preoperative anxiety and concerns in pancreatic cancer patients. The findings suggest that high anxiety levels are associated with more preoperative concerns, particularly related to surgical aspects. Depressive symptoms and trait anxiety were identified as risk factors for preoperative anxiety. Screening for psychological characteristics and providing support can help prevent the development of preoperative anxiety and surgery worries.

HEALTHCARE (2023)

Article Health Care Sciences & Services

Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial

Maarten Korrel, Leia R. Jones, Jony van Hilst, Gianpaolo Balzano, Bergthor Bjornsson, Ugo Boggi, Svein Olav Bratlie, Olivier R. Busch, Giovanni Butturini, Giovanni Capretti, Riccardo Casadei, Bjorn Edwin, Anouk M. L. H. Emmen, Alessandro Esposito, Massimo Falconi, Bas Groot Koerkamp, Tobias Keck, Ruben H. J. de Kleine, Dyre B. Kleive, Arto Kokkola, Daan J. Lips, Sanne Lof, Misha D. P. Luyer, Alberto Manzoni, Ravi Marudanayagam, Matteo de Pastena, Nicolo Pecorelli, John N. Primrose, Claudio Ricci, Roberto Salvia, Per Sandstrom, Frederique L. I. M. Vissers, Ulrich F. Wellner, Alessandro Zerbi, Marcel G. W. Dijkgraaf, Marc G. Besselink, Mohammad Abu Hilal

Summary: This is a non-inferiority trial comparing open distal pancreatectomy (ODP) with minimally invasive distal pancreatectomy (MIDP) in patients with resectable pancreatic cancer. The results show that MIDP is not inferior to ODP in terms of radical resection rates, and the postoperative outcomes and survival rates are comparable as well.

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Surgery

Blood loss predicts pancreas-specific complications only in high-risk patients: results of a prospective and systematic blood loss estimation during pancreatoduodenectomy

Giovanni Marchegiani, Giampaolo Perri, Federico Reich, Giuseppa Procida, Elisa Bannone, Roberto Salvia, Claudio Bassi

BRITISH JOURNAL OF SURGERY (2023)

Article Surgery

Pancreatic cystic neoplasms: Still high rates of preoperative misdiagnosis in the guidelines and endoscopic ultrasound era

Roberto Salvia, Anna Burelli, Angelica Nepi, Andrea Caravati, Claudia Tomelleri, Tommaso Dall'Olio, Fabio Casciani, Stefano Francesco Crino, Giampaolo Perri, Giovanni Marchegiani

Summary: This study aimed to reappraise diagnostic errors in patients undergoing surgery for presumed pancreatic cystic neoplasms. The study found that misdiagnosis and mismatch rates were still high, and some diagnostic errors had clinical relevance. New diagnostic tools are needed to improve the accuracy of diagnosing high-risk lesions.

SURGERY (2023)

Article Surgery

Artificial intelligence-based models to assess the risk of malignancy on radiological imaging in patients with intraductal papillary mucinous neoplasm of the pancreas: scoping review

Alberto Balduzzi, Boris V. Janssen, Matteo De Pastena, Tommaso Pollini, Giovanni Marchegiani, Henk Marquering, Jaap Stoker, Inez Verpalen, Claudio Bassi, Marc G. Besselink, Roberto Salvia

BRITISH JOURNAL OF SURGERY (2023)

Article Oncology

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study

Eran van Veldhuisen, Sjors Klompmaker, Quisette P. Janssen, Mohammed Abu Hilal, Adnan Alseidi, Alberto Balduzzi, Gianpaolo Balzano, Claudio Bassi, Frederik Berrevoet, Morgan Bonds, Olivier R. Busch, Giovanni Butturini, Kevin C. Conlon, Isabella M. Frigerio, Giuseppe K. Fusai, Johan Gagniere, Oonagh Griffin, Thilo Hackert, Asif Halimi, Tobias Keck, Joerg Kleeff, Ulla Klaiber, Knut J. Labori, Mickael Lesurtel, Giuseppe Malleo, Marco V. Marino, I. Quintus Molenaar, Michael B. Mortensen, Andrej Nikov, Michele Pagnanelli, Rupaly Pande, Per Pfeiffer, Daniel Pietrasz, Elena Rangelova, Keith J. Roberts, Antonio Sa Cunha, Roberto Salvia, Oliver Strobel, Timo Tarvainen, Johanna W. Wilmink, Bas Groot Koerkamp, Marc G. Besselink

Summary: This study aimed to evaluate the outcome of pancreatectomy after preoperative FOLFIRINOX chemotherapy, and found that this treatment is associated with favorable outcomes for patients with BRPC and LAPC. However, the number of preoperative chemotherapy cycles and the use of adjuvant chemotherapy are not related to survival rate.

ANNALS OF SURGICAL ONCOLOGY (2023)

No Data Available